The CDC Amends the Pfizer Booster Interval Period and the COVID-19 Vaccine Schedule for Immunocompromised 5-11 Year-Old Children

The CDC updates the recommendations for the Pfizer-BioNTech booster dose; the period is now shortened to five months after the second dose rather than 6 months as previously stated. 

Additionally, children who are immunocompromised between the ages of 5 to 11 years old are recommended to receive an additional primary dose 28 days after their second COVID-19 vaccine. 

Read the full media statement here